ADAM2 and lung carcinoma: In lung cancer, 71/510 (13.9%) of LUAD and 26/498 (5.2%) of LUSC tumors showed ADAM2 expression and ~50% of these cases showed ADAM2 amplifications, indicating that ADAM2 amplification correlates with ADAM2 expression (Supplementary Fig. 29a and Supplementary Data 5).